Blog August 12, 2024 Exciting New Resources for Your Managed Care Pharmacy Toolbox AMCP's Steve Kheloussi updates members of the MCP community on the newest resources for the managed care pharmacy toolbox. Formulary Management
Press Releases June 1, 2023 AMCP Welcomes Comments on Format for Formulary Submissions The AMCP Format public comment period facilitates an exchange of information between manufacturers and health care decision-makers to inform formulary and coverage decisions. Formulary Management, Formulary & Utilization Management
Resource April 12, 2018 AMCP submits letter to New York Senate committee opposing provisions of Assembly Bill 4306 - mandating conditions for medication synchronization AMCP comment letter on state legislation on medication synchronization. Biosimilars, Formulary Management, Legislation & Regulation, Managed Care Practice Issues
Resource February 28, 2018 AMCP submits letter to Connecticut Senate General Law Committee on Senate Bill 197 regarding Interchangeable Biologic Products AMCP comment letter on state legislation on interchangeable biologic products. Biosimilars, Formulary Management, Legislation & Regulation, Managed Care Practice Issues
Resource February 28, 2018 AMCP submits letter to New Hampshire Senate Health and Human Services Committee on Senate Bill 350 regarding Interchangeable Biologic Products Dispensed by Pharmacists AMCP comment letter on state legislation on interchangeable biologic products. Formulary Management, Legislation & Regulation, Managed Care Practice Issues, Biosimilars
Resource February 28, 2018 AMCP submits letter to Vermont House Committee on Health Care regarding Senate Bill 92 on Substitution of Interchangeable Biologic Products AMCP comment letter on state legislation on interchangeable biologic products. Biosimilars, Formulary Management, Legislation & Regulation, Managed Care Practice Issues
Resource February 28, 2018 AMCP Submits Letter to West Virginia Speaker of Delegates on House Bill 4524 and Establishing Guidelines for the Substitution of Certain Biologic Pharmaceuticals by Pharmacists AMCP comment letter on state legislation on pharmacist substitution of biologics. Biosimilars, Formulary Management, Legislation & Regulation, Managed Care Practice Issues
Resource February 27, 2018 AMCP Submits Letter to Alaska House Finance Committee Regarding Senate Bill 32 and the Regulation of Biologic Product Substitutions AMCP comments on state legislation on substitution of biologics. Biosimilars, Formulary Management, Legislation & Regulation, Managed Care Practice Issues
Resource February 27, 2018 AMCP submits letter to Wyoming Joint Labor, Health and Social Services Committee on Senate File 75 and Authorizing Pharmacists to Dispense Interchangeable Biologic Products AMCP comments on state legislation on interchangeable biologics. Biosimilars, Formulary Management, Legislation & Regulation, Managed Care Practice Issues
Resource February 12, 2018 AMCP Submits Letter to Speaker of Wisconsin Assembly regarding Assembly Bill 679 and the Regulations on Pharmacists Substituting Biological Products AMCP comment letter on state legislation on interchangeable biologic products. Formulary Management, Legislation & Regulation, Managed Care Practice Issues, Biosimilars
Resource January 7, 2018 AMCP sends letter to Michigan House Health Policy Committee citing concerns with HB 4472 and regulations on pharmacists substituting interchangeable biological products AMCP comments on state legislation on substitution of interchangeable biologics. Formulary Management, Legislation & Regulation, Managed Care Practice Issues, Biosimilars, Legislation & Regulation